Ibaraki, Japan

Atsuhiko Kubota

This inventor holds 20 USPTO granted patents, plus 2 CIPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Eisai Company, Limited, Eisai R&d Management Co., Ltd.. Active years: 1989-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atsuhiko Kubota. Retrieved from https://idiyas.com/inventor/atsuhiko-kubota

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 65.0


Average Co-Inventor Count = 10.6

ph-index = 8

Forward Citations = 471(Granted Patents)


Location History:

  • Niihari, JP (1994)
  • Sakuramura, JP (1989 - 1997)
  • Tsuchiura, JP (2005)
  • Ibaraki, JP (1990 - 2006)
  • Tsukuba, JP (1990 - 2012)

Company Filing History:


Years Active: 1989-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Benzimidazole Compound
Imidazopyridine Compound
Indole Derivative
Quinoline Derivatives
Isoquinoline Derivatives
Cyclic Amine Compounds
Piperidine Derivative
Oxazolidone Derivative
Fused Pyridine Derivatives
Acetylcholinesterase Activity
Pharmaceutical Composition
Disubstituted Derivatives
20 patents (USPTO):Explore Patents

Title: The Innovative Mind of Atsuhiko Kubota: A Pioneer in Pharmaceutical Patents

Introduction: Atsuhiko Kubota, an accomplished inventor based in Ibaraki, Japan, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 20 patents, Kubota has demonstrated his expertise in developing novel chemical compounds that aim to improve therapeutic outcomes for various medical conditions.

Latest Patents: Among his most recent innovations are two significant patents. The first is a **Benzimidazole compound**, which is a novel chemical useful as a therapeutic or prophylactic agent for acid-related diseases. This compound showcases excellent inhibitory effects against gastric acid secretion, helping to maintain a high intragastric pH for extended periods while ensuring safety and physicochemical stability.

The second notable invention is an **Imidazopyridine compound**, characterized by its versatile structure that allows for various modifications and substitutions. This compound has been designed to enhance therapeutic efficacy, providing a broad spectrum of potential benefits in treating several conditions.

Career Highlights: Atsuhiko Kubota has a commendable career, having worked with prestigious companies such as Eisai Company, Limited and Eisai R&D Management Co., Ltd. His time at these organizations has equipped him with valuable insights and expertise, further fueling his innovative spirit in the pharmaceutical industry.

Collaborations: Throughout his career, Kubota has collaborated with talented individuals, including Atsushi Sasaki and Hachiro Sugimoto. These partnerships have fostered a creative environment conducive to significant advancements in their respective fields.

Conclusion: Atsuhiko Kubota is a remarkable inventor whose work has considerably impacted the pharmaceutical landscape. His innovative compounds and collaborative efforts continue to push the boundaries of medical science, paving the way for new therapeutic solutions and enhanced patient care. With a commitment to excellence and a keen eye for innovation, Kubota's contributions to the field are invaluable and deserving of recognition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…